======= PIK3R1 ======= == Gene Information == * **Official Symbol**: PIK3R1 * **Official Name**: phosphoinositide-3-kinase regulatory subunit 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5295|5295]] * **UniProt**: [[https://www.uniprot.org/uniprot/P27986|P27986]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PIK3R1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PIK3R1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/171833|Open OMIM]] == Function Summary == * **Entrez Summary**: Phosphatidylinositol 3-kinase phosphorylates the inositol ring of phosphatidylinositol at the 3-prime position. The enzyme comprises a 110 kD catalytic subunit and a regulatory subunit of either 85, 55, or 50 kD. This gene encodes the 85 kD regulatory subunit. Phosphatidylinositol 3-kinase plays an important role in the metabolic actions of insulin, and a mutation in this gene has been associated with insulin resistance. Alternative splicing of this gene results in four transcript variants encoding different isoforms. [provided by RefSeq, Jun 2011]. * **UniProt Summary**: N/A |RhoGAP| |SH2| |phosphatidylinositol 3-kinase complex, class IA| |ErbB-3 class receptor binding| |phosphatidylinositol 3-kinase regulator activity| |perinuclear endoplasmic reticulum membrane| |insulin binding| |neurotrophin TRKA receptor binding| |phosphatidylinositol 3-kinase regulatory subunit binding| |insulin receptor substrate binding| |positive regulation of endoplasmic reticulum unfolded protein response| |transmembrane receptor protein tyrosine kinase adaptor activity| |insulin-like growth factor receptor signaling pathway| |1-phosphatidylinositol-3-kinase regulator activity| |insulin-like growth factor receptor binding| |growth hormone receptor signaling pathway| |phosphatidylinositol 3-kinase complex| |cellular response to growth hormone stimulus| |phosphatidylinositol 3-kinase binding| |insulin receptor binding| |regulation of endoplasmic reticulum unfolded protein response| |negative regulation of osteoclast differentiation| |ERBB2 signaling pathway| |phosphatidylinositol 3-kinase signaling| |extrinsic apoptotic signaling pathway via death domain receptors| |positive regulation of RNA splicing| |response to growth hormone| |positive regulation of response to endoplasmic reticulum stress| |positive regulation of protein import into nucleus| |positive regulation of glucose import| |negative regulation of cell-matrix adhesion| |positive regulation of protein import| |phosphotyrosine residue binding| |positive regulation of glucose transmembrane transport| |negative regulation of myeloid leukocyte differentiation| |epidermal growth factor receptor signaling pathway| |phosphatidylinositol phosphorylation| |regulation of phosphatidylinositol 3-kinase activity| |T cell costimulation| |regulation of glucose import| |positive regulation of protein localization to plasma membrane| |lymphocyte costimulation| |regulation of protein import into nucleus| |regulation of protein import| |positive regulation of protein localization to cell periphery| |regulation of lipid kinase activity| |negative regulation of cell-substrate adhesion| |positive regulation of nucleocytoplasmic transport| |regulation of insulin receptor signaling pathway| |cis-Golgi network| |regulation of osteoclast differentiation| |lipid phosphorylation| |vascular endothelial growth factor receptor signaling pathway| |intrinsic apoptotic signaling pathway in response to DNA damage| |ERBB signaling pathway| |phosphatidylinositol-mediated signaling| |regulation of cellular response to insulin stimulus| |regulation of glucose transmembrane transport| |positive regulation of protein localization to nucleus| |inositol lipid-mediated signaling| |negative regulation of myeloid cell differentiation| |regulation of stress fiber assembly| |cellular response to UV| |regulation of response to endoplasmic reticulum stress| |regulation of phospholipid metabolic process| |positive regulation of phosphatidylinositol 3-kinase signaling| |positive regulation of tumor necrosis factor production| |protein phosphatase binding| |insulin receptor signaling pathway| |cellular glucose homeostasis| |positive regulation of tumor necrosis factor superfamily cytokine production| |regulation of actomyosin structure organization| |regulation of actin filament bundle assembly| |regulation of protein localization to plasma membrane| |protein import into nucleus| |extrinsic apoptotic signaling pathway| |negative regulation of leukocyte differentiation| |regulation of nucleocytoplasmic transport| |B cell differentiation| |phosphatidylinositol biosynthetic process| |cellular response to light stimulus| |regulation of cell-matrix adhesion| |regulation of protein localization to cell periphery| |import into nucleus| |regulation of myeloid leukocyte differentiation| |regulation of protein localization to nucleus| |regulation of phosphatidylinositol 3-kinase signaling| |positive regulation of protein localization to membrane| |Fc-gamma receptor signaling pathway involved in phagocytosis| |regulation of RNA splicing| |immune response-regulating cell surface receptor signaling pathway involved in phagocytosis| |negative regulation of hemopoiesis| |platelet activation| |Fc receptor mediated stimulatory signaling pathway| |Fc-gamma receptor signaling pathway| |protein import| |response to UV| |regulation of tumor necrosis factor production| |intrinsic apoptotic signaling pathway| |regulation of tumor necrosis factor superfamily cytokine production| |B cell activation| |positive regulation of intracellular protein transport| |protein localization to nucleus| |cellular response to insulin stimulus| |positive regulation of protein kinase B signaling| |phosphatidylinositol metabolic process| |cell-cell junction| |Fc-epsilon receptor signaling pathway| |cellular response to radiation| |T cell receptor signaling pathway| |protein stabilization| |glucose homeostasis| |carbohydrate homeostasis| |regulation of protein localization to membrane| |positive regulation of T cell activation| |lipid modification| |positive regulation of transmembrane transport| |glycerophospholipid biosynthetic process| |positive regulation of intracellular transport| |regulation of cell-substrate adhesion| |positive regulation of leukocyte cell-cell adhesion| |regulation of protein kinase B signaling| |glycerolipid biosynthetic process| |regulation of myeloid cell differentiation| |response to insulin| |regulation of intracellular protein transport| |lymphocyte differentiation| |Fc receptor signaling pathway| |phospholipid biosynthetic process| |positive regulation of cell-cell adhesion| |response to endoplasmic reticulum stress| |axon guidance| |regulation of actin filament organization| |neuron projection guidance| |nucleocytoplasmic transport| |nuclear transport| |cellular response to peptide hormone stimulus| |negative regulation of cell adhesion| |regulation of leukocyte differentiation| |apoptotic signaling pathway| |regulation of protein stability| |blood coagulation| |coagulation| |antigen receptor-mediated signaling pathway| |regulation of leukocyte cell-cell adhesion| |hemostasis| |response to light stimulus| |glycerophospholipid metabolic process| |cellular response to environmental stimulus| |cellular response to abiotic stimulus| |regulation of T cell activation| |positive regulation of cellular protein localization| |cellular response to peptide| |phagocytosis| |leukocyte differentiation| |transcription factor binding| |regulation of actin cytoskeleton organization| |regulation of intracellular transport| |regulation of supramolecular fiber organization| |positive regulation of lymphocyte activation| |axonogenesis| |phospholipid metabolic process| |glycerolipid metabolic process| |leukocyte migration| |lymphocyte activation| |regulation of actin filament-based process| |response to peptide hormone| |regulation of lipid metabolic process| |regulation of cell-cell adhesion| |positive regulation of cell adhesion| |positive regulation of leukocyte activation| |axon development| |positive regulation of cell activation| |positive regulation of protein transport| |establishment of protein localization to organelle| |cell morphogenesis involved in neuron differentiation| |response to radiation| |negative regulation of immune system process| |immune response-activating cell surface receptor signaling pathway| |positive regulation of cytokine production| |regulation of hemopoiesis| |positive regulation of establishment of protein localization| |response to peptide| |wound healing| |neuron projection morphogenesis| |immune response-regulating cell surface receptor signaling pathway| |plasma membrane bounded cell projection morphogenesis| |protein heterodimerization activity| |cell projection morphogenesis| |regulation of body fluid levels| |positive regulation of cell migration| |transmembrane receptor protein tyrosine kinase signaling pathway| |cell part morphogenesis| |regulation of lymphocyte activation| |positive regulation of cell motility| |organophosphate biosynthetic process| |positive regulation of cellular component movement| |regulation of cellular protein localization| |regulation of cytoskeleton organization| |chemotaxis| |positive regulation of locomotion| |taxis| |cell morphogenesis involved in differentiation| |hemopoiesis| |immune response-activating signal transduction| |regulation of transmembrane transport| |response to wounding| |lipid biosynthetic process| |immune response-regulating signaling pathway| |cellular response to organonitrogen compound| |regulation of leukocyte activation| |cellular response to hormone stimulus| |hematopoietic or lymphoid organ development| |activation of immune response| |regulation of cell activation| |immune system development| |cellular response to nitrogen compound| |neuron projection development| |cytokine-mediated signaling pathway| |regulation of cell adhesion| |regulation of cytokine production| |viral process| |regulation of protein transport| |negative regulation of cell differentiation| |enzyme linked receptor protein signaling pathway| |cell morphogenesis| |regulation of cellular response to stress| |protein localization to organelle| |regulation of peptide transport| |cellular chemical homeostasis| |regulation of establishment of protein localization| |cellular response to DNA damage stimulus| |symbiotic process| |neuron development| |interspecies interaction between organisms| |cellular component morphogenesis| |regulation of cell migration| |positive regulation of immune response| |regulation of kinase activity| |organophosphate metabolic process| |negative regulation of apoptotic process| |cellular homeostasis| |negative regulation of programmed cell death| |response to hormone| |regulation of cell motility| |regulation of cellular localization| |apoptotic process| |leukocyte activation| |negative regulation of developmental process| |cellular lipid metabolic process| |regulation of cellular component biogenesis| |cell migration| |protein phosphorylation| |regulation of transferase activity| |regulation of locomotion| |positive regulation of transport| |negative regulation of cell death| |intracellular protein transport| |regulation of cellular component movement| |response to organonitrogen compound| |cellular response to cytokine stimulus| |neuron differentiation| |positive regulation of intracellular signal transduction| |regulation of protein localization| |programmed cell death| |cellular response to oxygen-containing compound| |cell activation| |localization of cell| |cell motility| |response to nitrogen compound| |immune effector process| |cell death| |response to cytokine| |chemical homeostasis| |plasma membrane bounded cell projection organization| |positive regulation of immune system process| |regulation of immune response| |cell projection organization| |response to abiotic stimulus| |negative regulation of multicellular organismal process| |lipid metabolic process| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |phosphorylation| |regulation of organelle organization| |locomotion| |G protein-coupled receptor signaling pathway| |response to endogenous stimulus| |regulation of response to stress| |protein transport| |intracellular transport| |generation of neurons| |peptide transport| |regulation of apoptotic process| |positive regulation of transcription, DNA-templated| |movement of cell or subcellular component| |response to oxygen-containing compound| |regulation of programmed cell death| |amide transport| |cellular protein localization| |regulation of phosphorylation| |cellular macromolecule localization| |establishment of protein localization| |neurogenesis| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |homeostatic process| |cell development| |regulation of immune system process| |positive regulation of signal transduction| |regulation of cell death| |intracellular signal transduction| |cellular response to stress| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |establishment of localization in cell| |nitrogen compound transport| |regulation of transport| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |vesicle-mediated transport| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |membrane| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|1.71| |[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|1.76| |[[:results:exp455|Benzoate 10000μM R08 exp455]]|1.78| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|1.81| |[[:results:exp13|Chloramphenicol 20μM R00 exp13]]|1.83| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|2.03| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|2.1| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|2.14| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|2.16| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|2.24| |[[:results:exp116|AICAR 240μM R03 exp116]]|2.36| ^Gene^Correlation^ |[[:human genes:m:mapkap1|MAPKAP1]]|0.456| |[[:human genes:p:pik3cd|PIK3CD]]|0.437| Global Fraction of Cell Lines Where Essential: 2/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|2/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12219 * **Expression level (log2 read counts)**: 8.24 {{:chemogenomics:nalm6 dist.png?nolink |}}